More on NXTS
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $13.00 |
|
|||
| Open | $6.62 | ||||
| 52 Wk High | $ | ||||
| 52 Wk Low | $ | ||||
| Day High | $6.90 | ||||
| Day Low | $5.42 | ||||
| P/E | N/A | ||||
| EPS | $ | ||||
| Volume | 2,071,686 | ||||
- Form 424B5 Nexentis Technologies
- Form 8-K Nexentis Technologies For: Jun 22
- MitoCareX Bio partners with Boltz on AI-driven SLC drug discovery
- Nexentis Technologies Announces International AI Drug Discovery Initiative Between MitoCareX Bio and Boltz to Accelerate Novel SLC Small-Molecule Discovery
- MitoCareX Bio completes SLC transport protein structural analysis
- Nexentis: Subsidiary MitoCareX Bio Successfully Completed Broad Analysis of SLC Transport Proteins to Support Discovery of Hard-to-Treat Cancers and Metabolic Diseases
- Form 424B5 Nexentis Technologies
- Form 8-K Nexentis Technologies For: Jun 12
- Form 8-K Nexentis Technologies For: May 27
- Nexentis unit achieves drug discovery milestone with improved molecule
Entities mentioned with NXTS
- Definitive Agreement | View Related Stories »
- Maynard Um | View Related Stories »
- Mark Zuckerberg | View Related Stories »
- ARK | View Related Stories »
- Show More...
